0001004878-17-000050.txt : 20170228
0001004878-17-000050.hdr.sgml : 20170228
20170227200924
ACCESSION NUMBER: 0001004878-17-000050
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170228
DATE AS OF CHANGE: 20170227
EFFECTIVENESS DATE: 20170228
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-281426
FILM NUMBER: 17644298
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
D
1
primary_doc.xml
X0707
D
LIVE
0000725363
CEL SCI CORP
8229 BOONE BLVD .
SUITE 802
VIENNA
VA
VIRGINIA
22182
7035069460
COLORADO
INTERLEUKIN 2 INC
Corporation
true
Geert
R.
Kersten
8229 Boone Blvd.
Suite 802
Vienna
VA
VIRGINIA
22182
Executive Officer
Director
Patricia
B.
Prichep
8229 Boone Blvd.
Suite 802
Vienna
VA
VIRGINIA
22182
Executive Officer
Eyal
Talor
8229 Boone Blvd.
Suite 802
Vienna
VA
VIRGINIA
22182
Executive Officer
Daniel
H.
Zimmerman
8229 Boone Blvd.
Suite 802
Vienna
VA
VIRGINIA
22182
Executive Officer
John
Cipriano
8229 Boone Blvd.
Suite 802
Vienna
VA
VIRGINIA
22182
Executive Officer
Alexander
G.
Esterhazy
20 Chemin du Pre-Poiset
CH-1253 Vandoeuvres
Geneve
V8
SWITZERLAND
00000
Director
Peter
R.
Young
208 Hewitt Drive
Suite 103-143
Waco
TX
TEXAS
76712
Director
Bruno
Baillavoine
8229 Boone Blvd.
Suite 802
Vienna
VA
VIRGINIA
22182
Director
Pharmaceuticals
$1 - $1,000,000
- 06b
false
2017-02-16
false
true
true
false
1000
N/A
None
H.C. Wainwright & Co., LLC
375
430 Park Avenue
New York
NY
NEW YORK
10022
All States
false
1000000
1000000
0
false
2
70000
0
142000
true
false
CEL SCI CORP
/s/ Geert R. Kersten
Geert R. Kersten
Chief Executive Officer
2017-02-27